PDS Biotechnology (PDSB) Return on Assets [ROA] (2015 - 2026)
PDS Biotechnology's Return on Assets [ROA] came in at -181.96% for Q2 2026, down 98.30 percentage points from -83.66% a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, PDS Biotechnology's Return on Assets [ROA] was -90.87%, down 19.06 percentage points from FY2024.
- Return on Assets [ROA] has declined in each of the last four years, with a five-year change of -25.44 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -71.81% in FY2024 (-8.84 pp), -62.97% in FY2023 (-6.30 pp), -56.66% in FY2022 (-22.17 pp) and -34.50% in FY2021 (+30.94 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] in data going back to Q4 2015.
- Year-over-year, Return on Assets [ROA] increased in 1 of the last seven quarters, with an average year-over-year change of -23.98 percentage points.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2021 (a gain of 41.90 percentage points), and the weakest in Q2 2026 (a drop of 98.30 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | PDS Biotechnology | 57.60 Mn | -22.61 Mn | - | -201.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -201.21% |
| Mar 31, 2026 | -120.95% |
| Dec 31, 2025 | -105.81% |
| Sep 30, 2025 | -92.80% |
| Jun 30, 2025 | -83.66% |
| Mar 31, 2025 | -76.84% |
| Dec 31, 2024 | -76.91% |
| Sep 30, 2024 | -71.81% |
| Jun 30, 2024 | -62.82% |
| Mar 31, 2024 | -68.36% |
| Dec 31, 2023 | -73.67% |
| Sep 30, 2023 | -84.64% |
| Jun 30, 2023 | -72.25% |
| Mar 31, 2023 | -57.81% |
| Dec 31, 2022 | -53.79% |
| Sep 30, 2022 | -42.84% |
| Jun 30, 2022 | -47.12% |
| Mar 31, 2022 | -34.85% |
| Dec 31, 2021 | -24.35% |
| Sep 30, 2021 | -19.61% |
API Access
PDS Biotechnology Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();